🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Dr. Bruce Haffty Bruce Haffty presents “Future of #BreastCancer #Radiation Oncology. Where will we be in 2030?” at Rutgers Cancer Institute’s Annual #Oncology #Clinical Practice and #Research Summit. #CancerNJ2023 RWJBarnabas Rutgers RWJMedSchool Rutgers Radiation Oncology Residency Program #radonc

Huge thank you to Bruce Haffty for providing some fantastic insights on key advancements and ongoing research on radiotherapy within breast cancer and other tumor types! RWJBarnabas Rutgers Cancer Institute #CancerNJ2023 #oncology

Proud of dr sung kim from Rutgers Cancer Institute Rutgers Radiation Oncology Residency Program expert panelist RSNA 2023 annual meeting.

.Rutgers Cancer Institute’s Dr. Bruce Haffty Bruce Haffty presents “Five-year outcomes of the IDEA trial of endocrine therapy without radiotherapy after breast-conserving surgery for postmenopausal patients age 50-69 with genomically-selected favorable...” at #SABCS23. sabcs.org/FullProgram

@bhaffty honored to be given the American radium society gold medal. Here with prior gold medalists rich hoppe Martin Coleman and Ritsuko Komaki. Rutgers Cancer Institute Rutgers Radiation Oncology Residency Program

Huge congrats to Dr. Bruce Haffty, the ARS Gold Medal Recipient, and Dr. Wally Curran, our Janeway speaker Bruce Haffty Wally Curran Amer. Radium Society

Fantastic presentation by Zohaib Sherwani, MD on our preop boost trial for which he received an American radium society travel grant award #ars2024 @bhaffty Rutgers Cancer Institute Rutgers Radiation Oncology Residency Program

Proud of our breast teams efforts in getting this institutional trial published. Congrats to all. Rutgers Radiation Oncology Residency Program Rutgers Cancer Institute @bhaffty

1 - A Randomized Trial of Hypofractionated Post-Mastectomy Radiation Therapy (PMRT) in Women with Breast Reconstruction (RT CHARM, A221505) ASTRO plenary Lead author M Poppe Coauthors @bhaffty and A khan. All originally from Rutgers Radiation Oncology Residency Program Rutgers Cancer Institute

The concept of the trial was born at @RutgCancer where we conducted the phase 2 published in Journal of Clinical Oncology by khan Poppe Bruce Haffty Rutgers Radiation Oncology Residency Program

10 yrs in the making, from concept to plenary, the results of RT CHARM are here. Congrats M Poppe Bruce Haffty and all investigators. To summarize, non inferiority is demonstrated with mod hypofx in PMRT patients with recon. Addl data across arms on predict of recon comps #ASTRO24

We are proud that 3 of the 4 plenary talks at ASTRO had authors from Rutgers Radiation Oncology Residency Program Rutgers Cancer Institute @bhaffty Salma Jabbour Rahul R. Parikh, MD, MBA Congrats to all. Amazing.

Learning the ins and outs of cancer center management with RadOnc Giants Ted Lawrence, Jerry Jaboin Bruce Haffty Wally Curran never stop growing, never stop questioning.

Molly Molly Chakraborty did a great job. 3rd year med student oral presentation ASTRO @bhaffty Rutgers Radiation Oncology Residency Program Rutgers Cancer Institute

Truly a great visit and lecture from arjun sahgal from sunnybrook Toronto. He is the authority and guru on spinal radiosurgery. Rutgers Radiation Oncology Residency Program Rutgers Cancer Institute Bruce Haffty

Excited to be presenting my work with Bruce Haffty Zohaib Sherwani, MD Lakshmi R Narra Zeinab Abou Yehia Sachin Jhawar at #SABCS24 !

Excited to debate Bruce Haffty on the role of biosignature testing for patients diagnosed with DCIS at miami breast conference this afternoon #bcsm

Proud of Firas E presentation of oncotype after preop boost at Miami Breast. ⁦Bruce Haffty⁩ ⁦Rutgers Cancer Institute⁩

Great and fun panel discussion on “Which Patients with DCIS Should Receive Biologic Signature Risk Recurrence Testing?” Bruce Haffty Chirag Shah